Dr. Clemens Schirmer MD, PhD, FAANS

Dr. Schirmer earned his medical degree and a doctorate in medical research from Ludwig-Maximilians University in Munich, Germany and at Harvard Medical School under the auspices of the Harvard Munich Alliance for Medical Education. He then completed his residency in neurosurgery and fellowship in interventional neuroradiology at the Tufts Medical Center program in Boston. ABNS board certified in neurological surgery and holding CAST certificates both in neuroendovascular surgery and neurocritical care, he currently serves as vice chair in the department of neurosurgery and is professor of neurosurgery and neuroscience in the unmodified research track at the Geisinger Commonwealth School of Medicine. Dr. Schirmer also serves as the system director of the Geisinger Comprehensive Stroke Centers and System Director of Cerebrovascular and Endovascular Neurosurgery, specializing in the treatment of stroke and related vascular disorders of the brain and spine using surgery, endovascular and radiation modalities. He is the program director of the Geisinger Neurosurgery residency training program and the CAST Neuroendovascular Fellowship program. His research interests focus on the quality metrics, variation of care, shared decision making and patient centered outcomes, genomics and biomarkers of stroke, machine learning and data analytics. He serves as principal investigator of several clinical trials in the stroke arena aiming to bringing novel and innovative therapies to the market and creating premier Geisinger initiatives. He serves as chair-elect of the AANS/CNS Cerebrovascular Section and the executive committee of the Congress of Neurological Surgeons where he is co-chair of the International Division and on the board of the CNS foundation, chair of the public relations and communications subcommittee of the AANS/CNS Washington Committee and Advisor to the AMA RBRVS RUC Committee. He has been appointed to MEDCAC and appointed to the Premier Group Purchasing Organization Member Cardiovascular Advisory Committee and multiple CMS/Acumen Cost- and Medicare Spending per Beneficiary- Measure Development Panels.